Inhibitors of Hepatitis C virus
Compounds of Formula I are disclosed, as well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical 5 compositions containing said compounds are also disclosed.
Saved in:
| Main Authors | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
06.06.2019
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Compounds of Formula I are disclosed, as well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical 5 compositions containing said compounds are also disclosed. |
|---|---|
| AbstractList | Compounds of Formula I are disclosed, as well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical 5 compositions containing said compounds are also disclosed. |
| Author | Yang, Zheng-Yu Kato, Darryl Zipfel, Sheila Bjornson, Kyla Vivian, Randall W Zablocki, Jeff Kobayashi, Tetsuya Taylor, James G Schrier, Adam James Karki, Kapil Kumar Canales, Eda Link, John O Cottell, Jeromy J Sangi, Michael Siegel, Dustin Phillips, Barton W Martin, Teresa Alejandra Trejo Pyun, Hyung-jung Katana, Ashley Anne Martinez, Ruben Tran, Chinh Viet |
| Author_xml | – fullname: Kobayashi, Tetsuya – fullname: Schrier, Adam James – fullname: Vivian, Randall W – fullname: Zipfel, Sheila – fullname: Canales, Eda – fullname: Martin, Teresa Alejandra Trejo – fullname: Kato, Darryl – fullname: Bjornson, Kyla – fullname: Yang, Zheng-Yu – fullname: Cottell, Jeromy J – fullname: Martinez, Ruben – fullname: Pyun, Hyung-jung – fullname: Tran, Chinh Viet – fullname: Sangi, Michael – fullname: Zablocki, Jeff – fullname: Katana, Ashley Anne – fullname: Siegel, Dustin – fullname: Karki, Kapil Kumar – fullname: Link, John O – fullname: Taylor, James G – fullname: Phillips, Barton W |
| BookMark | eNrjYmDJy89L5WSQ98zLyEzKLMkvKlbIT1PwSC1ILMksySxWcFYoyywqLeZhYE1LzClO5YXS3Awqbq4hzh66qQX58anFBYnJqXmpJfGOoUYGhuZGBsaWFiZOTkbGRCoDAMvwJ70 |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | AU2017203984BB2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_AU2017203984BB23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Nov 08 04:49:35 EST 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_AU2017203984BB23 |
| Notes | Application Number: AU20170203984 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190606&DB=EPODOC&CC=AU&NR=2017203984B2 |
| ParticipantIDs | epo_espacenet_AU2017203984BB2 |
| PublicationCentury | 2000 |
| PublicationDate | 20190606 |
| PublicationDateYYYYMMDD | 2019-06-06 |
| PublicationDate_xml | – month: 06 year: 2019 text: 20190606 day: 06 |
| PublicationDecade | 2010 |
| PublicationYear | 2019 |
| RelatedCompanies | GILEAD SCIENCES, INC |
| RelatedCompanies_xml | – name: GILEAD SCIENCES, INC |
| Score | 3.203889 |
| Snippet | Compounds of Formula I are disclosed, as well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical 5 compositions... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | Inhibitors of Hepatitis C virus |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190606&DB=EPODOC&locale=&CC=AU&NR=2017203984B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAR3Zm5aWYqprkZpmogusoZN1k4AdOF3DRDMzU-OUxMQk8Iyur5-ZR6iJV4RpBBNDDmwvDPic0HLw4YjAHJUMzO8l4PK6ADGI5QJeW1msn5QJFMq3dwuxdVGD9o6BtRuwQa7m4mTrGuDv4u-s5uwM7Emq-QWB5EATjpYWJk7AApsV2JA2B-UH1zAn0L6UAuRKxU2QgS0AaF5eiRADU2qeMAOnM-zuNWEGDl_olDeQCc19xSIM8p55GZlJmaD7cRTy0xQ8UkGroUsyixWcFcoyi0qLRRlU3FxDnD10gTbFwz0W7xiK5CwnI2MxBhZgnz9VgkHB3MzSCJj5koBVDGheMNESNPJgkQi6s9vCyDIxRZJBFq9RUgTkpRm4QKEFXvNkJsPAUlJUmioLrF1LkuTAgQIAjBh7Vw |
| link.rule.ids | 230,309,783,888,25576,76882 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAR3Zm5aWYqprkZpmogusoZN1k4AdOF3DRDMzU-OUxMQk8Iyur5-ZR6iJV4RpBBNDDmwvDPic0HLw4YjAHJUMzO8l4PK6ADGI5QJeW1msn5QJFMq3dwuxdVGD9o6BtRuwQa7m4mTrGuDv4u-s5uwM7Emq-QWB5EATjpYWJk7AApsV2Mi2AN134BrmBNqXUoBcqbgJMrAFAM3LKxFiYErNE2bgdIbdvSbMwOELnfIGMqG5r1iEQd4zLyMzKRN0P45CfpqCRypoNXRJZrGCs0JZZlFpsSiDiptriLOHLtCmeLjH4h1DkZzlZGQsxsAC7POnSjAomJtZGgEzXxKwigHNCyZagkYeLBJBd3ZbGFkmpkgyyOI1SoqAvDwDp0eIr0-8j6eftzQDFyjkwOufzGQYWEqKSlNlgTVtSZIcOIAAe_p-Rw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Inhibitors+of+Hepatitis+C+virus&rft.inventor=Kobayashi%2C+Tetsuya&rft.inventor=Schrier%2C+Adam+James&rft.inventor=Vivian%2C+Randall+W&rft.inventor=Zipfel%2C+Sheila&rft.inventor=Canales%2C+Eda&rft.inventor=Martin%2C+Teresa+Alejandra+Trejo&rft.inventor=Kato%2C+Darryl&rft.inventor=Bjornson%2C+Kyla&rft.inventor=Yang%2C+Zheng-Yu&rft.inventor=Cottell%2C+Jeromy+J&rft.inventor=Martinez%2C+Ruben&rft.inventor=Pyun%2C+Hyung-jung&rft.inventor=Tran%2C+Chinh+Viet&rft.inventor=Sangi%2C+Michael&rft.inventor=Zablocki%2C+Jeff&rft.inventor=Katana%2C+Ashley+Anne&rft.inventor=Siegel%2C+Dustin&rft.inventor=Karki%2C+Kapil+Kumar&rft.inventor=Link%2C+John+O&rft.inventor=Taylor%2C+James+G&rft.inventor=Phillips%2C+Barton+W&rft.date=2019-06-06&rft.externalDBID=B2&rft.externalDocID=AU2017203984BB2 |